Midwest Heart & Vascular Specialists

Overland Park, Kansas 66211

1 studies enrolling now · 6 studies all time

What they study most

AL Amyloidosis, ATTR Amyloidosis Wild Type, Acute Myocardial Infarction, Amyloid, Amyloidosis Cardiac, Atherosclerosis, Cardiac Amyloidosis, Coronary Artery Disease, Heart Failure With Preserved Ejection Fraction (HFpEF), Hypercholesterolemia, Infiltrative Cardiomyopathy, Amyloid, Obesity

Studies at this site

• A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis — Recruiting now
• A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial — Completed
• Amyloidosis Incidence in High-Risk Cardiac Device Patients — Status unconfirmed
• Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack — Completed
• DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry — Status unconfirmed
• Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin — Completed